Did John Hoeven buy Bristol Myers Squibb stock?

Common questions

Did John Hoeven buy Bristol Myers Squibb stock?

Yes. John Hoeven disclosed 1 purchase and 1 sale of Bristol Myers Squibb (BMY) stock between Aug 22, 2016 and Jan 20, 2017, in STOCK Act reports. Added together, the disclosed purchases come to $50K-$100K and the disclosed sales to $50K-$100K.

How big were John Hoeven's Bristol Myers Squibb trades?

STOCK Act reports give a range for each trade, such as $50K-$100K, never an exact amount. Added together, the disclosed purchases come to $50K-$100K and the disclosed sales to $50K-$100K.

Did John Hoeven make these Bristol Myers Squibb trades personally?

Not always. The STOCK Act requires members to report trades by themselves, a spouse and dependent children. The owner column of each linked filing says whose trade it was.

Does John Hoeven still own Bristol Myers Squibb stock?

This page lists reported trades, not holdings. A purchase can have been sold since, and the filings shown do not say what is held today.

When did John Hoeven report these trades?

The latest filing is dated Jan 25, 2017. The STOCK Act gives members of Congress 45 days to report a trade, so a filing can trail the trade by weeks. Every row shows both dates.

Where does this data come from?

From periodic transaction reports filed under the STOCK Act with the Secretary of the Senate. Every trade links to the original filing.